...
首页> 外文期刊>Oncogene >Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations
【24h】

Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations

机译:RET跨膜结构域的自缔合通过MEN2A突变致癌性激活。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In patients with medullary thyroid carcinoma (MTC) and type 2A multiple endocrine neoplasia (MEN2A), mutations of cysteine residues in the extracellular juxtamembrane region of the RET receptor tyrosine kinase cause the formation of covalent receptor dimers linked by intermolecular disulfide bonds between unpaired cysteines, followed by oncogenic activation of the RET kinase. The close proximity to the plasma membrane of the affected cysteine residues prompted us to investigate the possible role of the transmembrane (TM) domain of RET (RET-TM) in receptor–receptor interactions underlying dimer formation. Strong self-association of the RET-TM was observed in a biological membrane. Mutagenesis studies indicated the involvement of the evolutionary conserved residues Ser-649 and Ser-653 in RET-TM oligomerization. Unexpectedly, RET-TM interactions were also abrogated in the A639G/A641R double mutant, first identified in a sporadic case of MTC. In agreement with this, no transforming activity could be detected in full-length RET carrying the A639G and A641R mutations, which remained fully responsive to glial cell-line-derived neurotrophic factor (GDNF) stimulation. When introduced in the context of C634R – a cysteine replacement that is prevalent in MEN2A cases – the A639G/A641R mutations significantly reduced dimer formation and transforming activity in this otherwise highly oncogenic RET variant. These data suggest that a strong propensity to self-association in the RET-TM underlies – and may be required for – dimer formation and oncogenic activation of juxtamembrane cysteine mutants of RET, and explains the close proximity to the plasma membrane of cysteine residues implicated in MEN2A and MTC syndromes.
机译:在患有甲状腺髓样癌(MTC)和2A型多发性内分泌肿瘤(MEN2A)的患者中,RET受体酪氨酸激酶胞外近膜区域中的半胱氨酸残基突变导致共价受体二聚体的形成,该共价受体二聚体由未配对的半胱氨酸之间的分子间二硫键连接,然后是RET激酶的致癌激活。受影响的半胱氨酸残基与质膜非常接近,促使我们研究RET的跨膜(TM)结构域(RET-TM)在二聚体形成背后的受体-受体相互作用中的可能作用。在生物膜中观察到了RET-TM的强自缔合。诱变研究表明,进化保守的残基Ser-649和Ser-653参与RET-TM寡聚。出乎意料的是,A639G / A641R双重突变体也取消了RET-TM相互作用,该突变体首先在零星的MTC病例中发现。与此相符的是,在携带A639G和A641R突变的全长RET中未检测到任何转化活性,这些突变仍对神经胶质细胞系神经营养因子(GDNF)的刺激完全起反应。当在C634R(在MEN2A病例中很普遍的半胱氨酸替代品)中引入时,A639G / A641R突变显着降低了这种原本高度致癌的RET变体的二聚体形成和转化活性。这些数据表明,RET-TM中很强的自我缔合倾向是RET的近膜半胱氨酸突变体的二聚体形成和致癌激活的基础,并且可能是必需的,并解释了与RET-TM紧密相关的半胱氨酸残基与质膜的紧密距离。 MEN2A和MTC综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号